Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 70 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 9062075

    Tetrahydropyridine derivatives as FabI inhibitors

    Aurigene Discovery Technologies Limited · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  2. US 9060971

    Combination pharmaceutical agents as inhibitors of HCV replication

    Enanta Pharmaceuticals, Inc. · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  3. US 9056891

    Synthetic peptide inhibitors of Wnt pathway

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted

  4. US 9051249

    Benzylamine derivatives as inhibitors of plasma kallikrein

    KalVista Pharmaceuticals Limited · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  5. US 9051319

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  6. US 9045416

    WNT protein signalling inhibitors

    The Board of Regents of the University of Texas System · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  7. US 9045559

    Method for screening inhibitors of interleukin-32 (IL-32)

    The Regents of the University of Colorado · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  8. US 9045443

    Nitric oxide donor neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  9. US 9044483

    Cell death inhibition by macrophage migration inhibitory factor and a binding substance thereto

    Takeda Pharmaceutical Company Limited · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  10. US 9040542

    Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pryimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea

    Vertex Pharmaceuticals Incorporated · Granted May 26, 2015 · Expires May 21, 2035

    granted

  11. US 9040522

    6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

    Takeda Pharmaceutical Company Limited · Granted May 26, 2015 · Expires May 21, 2035

    granted

  12. US 9040527

    Pyrimidinediamine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 26, 2015 · Expires May 21, 2035

    granted

  13. US 9034903

    Acyl piperidine inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted May 19, 2015 · Expires May 14, 2035

    granted

  14. US 9034311

    Pyridin-2(1 H)-one derivatives as JAK inhibitors

    Almirall, S.A. · Granted May 19, 2015 · Expires May 14, 2035

    granted

  15. US 9029546

    Pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2015 · Expires May 7, 2035

    granted

  16. US 9029550

    Conformationally restricted urea inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted May 12, 2015 · Expires May 7, 2035

    granted

  17. US 9029502

    Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 12, 2015 · Expires May 7, 2035

    granted

  18. US 9029344

    Linked purine pterin HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 12, 2015 · Expires May 7, 2035

    granted

  19. US 9023340

    Wnt inhibitors for human stem cell differentiation

    ChemRegen, Inc. · Granted May 5, 2015 · Expires Apr 30, 2035

    granted

  20. US 9023858

    Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 5, 2015 · Expires Apr 30, 2035

    granted

  21. US 9023356

    Treatment method using EGFR antibodies and SRC inhibitors and related formulations

    The Regents of the University of California · Granted May 5, 2015 · Expires Apr 30, 2035

    granted

  22. US 9018201

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  23. US 9018238

    Inhibitor of casein kinase 1δ and casein kinase 1ε

    Pharmadesign, Inc. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  24. US 8999982

    Pharmaceutically active compounds as Axl inhibitors

    Lead Discovery Center GmbH · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.